Financial Year |
March 31 2023 |
Monetary Funds |
4,338,153,687.77 |
Held-for-trading Financial Assets |
837,337,454.42 |
Notes Receivable |
-- |
Accounts Receivable |
806,640,763.64 |
Advances to Suppliers |
172,917,485.82 |
Other Receivables |
43,994,541.23 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
179,241.63 |
Inventories |
3,143,341,685.76 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
1,265,978,888.84 |
Other Current Assets |
168,781,226.62 |
Total Current Assets |
11,389,498,351.93 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
1,117,147,261.72 |
Investment Properties |
154,207,460.42 |
Fixed Assetes |
22,147,955,249.53 |
Under-construction Projects |
965,783,182.37 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
141,273,437.31 |
R&D expenses |
-- |
Goodwill |
3,609,824.44 |
Long-Term Deferred and Prepaid Expenses |
15,105,891.91 |
Deferred Income Tax Assets |
345,611,906.61 |
Other Non-Current Assets |
348,366,362.78 |
Sub-Total of Non-Current Assets |
25,954,195,747.86 |
Total Assets |
37,343,694,099.79 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
93,017,567.56 |
Accounts Payable |
1,460,810,257.79 |
Accounts Received In Advance |
42,779,621.61 |
Employee Compensation Payable |
128,073,038.21 |
Taxes Payable |
233,620,566.77 |
Interest Payable |
-- |
Dividend Payable |
60,526,218.32 |
Other payables |
440,575,983.73 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
2,319,443,703.01 |
Other Current Liabilities |
3,398,675,995.73 |
Sub-Total of Current Liabilities |
9,650,315,378.90 |
Long-term Loans |
896,005,000.00 |
Bonds Payable |
3,994,161,931.08 |
Long-Term Accounts Payable |
2,802,187,500.00 |
Special Payable |
-- |
Estimatied Liabilities |
19,920,327.09 |
Deferred Income Tax Liabilities |
111,793,506.71 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
8,629,185,527.86 |
Total Liabilities |
18,279,500,906.76 |
Paid-In Capital(Or Share Stock) |
2,335,407,014.00 |
Capital Surplus |
1,811,616,956.00 |
Surplus Reserve |
1,742,176,713.38 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
11,248,469,616.55 |
Minority Stockholder's Interest |
1,852,931,590.28 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,211,261,602.75 |
Owner's Equity(Stockholder's Equity) |
19,064,193,193.03 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
37,343,694,099.79 |